Case Study:
Finding New Insights Why Physicians Are Increasing or Decreasing their Prescribing of a Specific Brand Using AI
Finding New Insights Why Physicians Are Increasing or Decreasing their Prescribing of a Specific Brand Using AI
The Client
The client had conducted market research but it failed to explain some of the increases and decreases seen and they wanted to get a more granular real world data insight into some of the prescribing changes seen.
The Solution
They decided to turn to Artificial Intelligence to see if real world data could explain some of the things seen. We were able to access Prescribing data by physician on a monthly basis. On top of that we also had claims data which we could link to the physician, as well as physician profile data from AMA. This combination of data allowed us to find patterns in the data that shed some light on some of the prescribing changes. For example some physicians were constrained by their health plans which impacted this client brand, some geographic locations led to higher prescribing on brands (and we were able to then look at company internal data to understand some of the reasons behind this based on their activity),
The Outcome
A clearer understanding of some of the prescribing behaviour could be identified and the company then could develop plans to address them.
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
How Pharma Companies Can Build Trustworthy AI Agents
In an industry where a single miscalculation can impact millions of lives, pharmaceutical companies are witnessing an unprecedented transformation through AI agents – autonomous systems
AI Agents: Pharma’s New Power Players
In an era where technology’s relentless advance is pushing the boundaries of what’s possible, the pharmaceutical industry finds itself at the threshold of a transformative
Is GenAI Mindset Holding Back Your Results?
In the rapidly evolving pharmaceutical landscape, Generative AI stands as both a transformative force and a test of the industry’s readiness for change. As 2025